What do we stand to gain from CRISPR gene editing?

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

In the world of biology — and coming soon to the wider world — enthusiasm and optimism continue to spread about CRISPR, a technology that allows precise editing of DNA.

If you’re a scientist who works with genes, it has already rocked your world: You can now snip an unwanted gene out of a DNA strand and replace it with another. Unlike the expensive blitz approaches of previously developed gene therapies, CRISPR techniques allow scientists to zero in on and knock out one problematic sequence. A process that used to be difficult, slow and haphazard has become a whole lot easier, faster and cheaper, opening up applications from medicine to agriculture. As journalist Carl Zimmer says: “Nobody’s found any place where it doesn’t work.”

CRISPR, an acronym for the unwieldy phrase “Clustered Regularly Interspaced Short Palindromic Repeats,” is now being tested with mosquitos to counter malaria and Zika; used to engineer disease-resistant livestock; and targeted to remove things like HIV and cystic fibrosis from human DNA. But more controversially, CRISPR has also been used by researchers in China in experiments on human embryos.

So while CRISPR first piqued public interest with its microscopic edge, attention has shifted to its macro footprint. How will it affect humanity? What are we going to use it to change? How will we make laws and pacts about it? Will it give rise to a new eugenics movement of cosmetically spruced-up genes and CRISPR’d test-tube babies?

Read full, original post: Scientists are trying to use CRISPR to fix everything. What’s wrong with that?

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.